论文部分内容阅读
目的:探讨疏血通注射液联合磷酸肌酸钠治疗急性冠脉综合征的临床疗效。方法:以130例急性冠脉综合征患者为研究对象,采取双盲、随机、双模拟和对照研究的方法,将其分为治疗组及对照组,各65例,两组患者均行常规处理,对照组患者单药疏血通注射液治疗,观察组患者应用疏血通注射液联合磷酸肌酸钠治疗,比较两组患者临床症状及生化指标改善情况。结果:治疗组患者临床症状、血浆生化指标改善均优于对照组,两组患者比较差异明显有统计学意义(P<0.05)。结论:疏血通注射液联合磷酸肌酸钠治疗急性冠脉综合征,可明显降低患者CRP、BNP水平,对于改善患者心肌缺血,提高患者生活质量有积极意义。
Objective: To investigate the clinical effect of Shuxuetong injection and sodium creatine phosphate in the treatment of acute coronary syndrome. Methods: A total of 130 patients with acute coronary syndrome were enrolled in this study. The patients were divided into treatment group and control group by double-blind, randomized, double-dummy and controlled study, 65 cases in each. Both groups were treated routinely , The control group patients with single drug Shuxuetong injection treatment, the observation group patients with Shuxuetong injection combined with sodium creatine phosphate treatment, the clinical symptoms and biochemical indicators were compared to improve the two groups. Results: The clinical symptoms and the improvement of plasma biochemical indexes in the treatment group were better than those in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Shuxuetong injection combined with sodium creatine phosphate in the treatment of acute coronary syndrome can significantly reduce the level of CRP and BNP in patients with myocardial ischemia, and improve the quality of life of patients with positive.